A leading technology brand
neuroConn is our leading technology brand from Germany. For almost twenty years our brand has been associated with practice-oriented medical technology used in neuroscience and clinical research, as well as in the diagnosis and treatment of neuropsychological disorders.
In close cooperation with leading research institutions and clinics worldwide, neuroConn technology is designed following the latest medical research standards, providing users with standardized and clinically evaluated protocols.
Trusted in research
neuroConn technology is the pioneer of combining non-invasive brain stimulation (tES) with neuroimaging. Together with our partners we work on neuronavigation (Rogue Research), target engagement (Brainclinics), closed-loop and interference stimulation methods for improving outcomes of non-invasive brain stimulation.
Neuromodulation therapies for clinicians
Our technology is used in many clinics and practices world-wide. The devices help patients with mental disorders, chronic pain and in rehabilitation.
THERA PRAX® offers evidence-based SCP neurofeedback based on detailed scientific research. The DC-STIMULATOR improves the activity of the affected brain areas through weak direct current. The neuroLAB offers a one-stop laboratory for neuropsychological testing and quantitative EEG analysis.
Our product lines
Electrical brain stimulators for clinical practice and research in tDCS, tACS and tRNS. Compatible with advanced EEG and Neuroimaging.
Neurofeedback systems for clinical practice and research with optional Biofeedback extensions and precision artefact control.
Electroencephalogram (EEG) technology, purpose-built and compatible with neuromodulation modalities for practice and research.
Neuropsychological tests and quantitative EEG analysis designed for laboratory or clinical use.
Closed-Loop solutions for applications in EEG and Neurostimulation
Biofeedback system for heart rate determination
Current research projects
Elektrisch stimulierte Atmung - ElekSA
(2021 VF 0036)
Project supported by the State of Thuringia (Germany), co-financed by funds of the European Union within the framework of the European Regional Development Fund (EFRE) and REACT-EU.